Increased risk for anxiety may begin before birth, shaped by infection or stressful events during pregnancy, according to a new preclinical study from researchers at Weill Cornell Medicine. While scientists have long known that maternal difficulty during pregnancy may raise a child’s risk for psychiatric illness, the biological pathways between these prenatal experiences and later mental health have been unclear.
December 2025 EIPM Director's Memo
December 10, 2025
Dear Friends & Members of the Englander Institute,
Bridging the gap between lab research and clinical care
December 3, 2025
Q: Ben, you're the EIPM's Director of Ex Vivo Models. Can you explain what you do?
A: Sure. The EIPM Ex Vivo Models Group receives tissues from patients with cancer, usually advanced cases. Our team builds organoid models of these tumors to test different therapeutics, aiming to find new treatments and improve patient care. The overarching goal is to translate research findings into the clinic to benefit patients.
EIPM Director's November 2025 Newsletter
November 4, 2025
Dear Friends & Members of the Englander Institute,
Cancer Progression Illuminated by New Multi-Omics Tool
October 31, 2025
Friday, October 10, 2025
A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track multiple gene mutations while simultaneously recording gene activity in individual cancer cells.
Study Finds Restoring Order to Dividing Cancer Cells May Prevent Metastasis
October 31, 2025
Friday, October 3, 2025
Triple negative breast cancer (TNBC) is one of the most aggressive and hardest to treat breast cancers, but a new study led by Weill Cornell Medicine suggests a way to stop it from spreading. Researchers have discovered that an enzyme called EZH2 drives TNBC cells to divide abnormally, which enables them to relocate to distant organs.
Galvanizing Blood Vessel Cells to Expand for Organ Transplantation
October 16, 2025
Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the laboratory, producing more than enough cells to replace damaged blood vessels or nourish organs for transplantation, according to a preclinical study by Weill Cornell Medicine investigators. Endothelial cells form the inner lining of blood vessels and regulate blood flow, inflammation and healing. Traditional approaches for growing these cells in the lab have yielded only limited numbers before they lose their ability to function.
Research at Risk: Rooting out treatment-resistant prostate cancer
October 7, 2025
Advances in prostate cancer early detection and treatment have improved outcomes in men diagnosed with the disease. Yet doctors and scientists have long been vexed by a question: Why do most men whose prostate cancer initially responds to hormonal-blocking therapy later develop a lethal, treatment-resistant form of the disease?
EIPM's 3Q External Newsletter
October 5, 2025
Welcome to third quarterly external newsletter of 2025!
Fischbach-Teschl to lead Engineering Innovations in Medicine initiative
September 25, 2025
Engineering Innovations in Medicine, an initiative launched by Cornell Engineering and Weill Cornell Medicine in 2022 to transform human health through data-driven innovation and interdisciplinary collaboration, will now be led by Claudia Fischbach-Teschl as part of her portfolio as James M. and Marsha McCormick Family Director of the Meinig School of Biomedical Engineering.
